Author

Martina Haselberger

Observed names: Haselberger, Martina, Martina Hasselberger

Observed institutions: University Hospital Regensburg, Klinikum Passau, Caritas-Krankenhaus St. Josef, University of Regensburg

ORCID: 0000-0001-6166-4255

Observed ORCID: 0000-0001-6166-4255

OpenAlex ID: A5025538797

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)

2021 · Nina N. Kleineberg, Samuel Knauss, et al. · European Journal of Neurology · 32

PDF

Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry

2022 · Norbert Stefan, Katrin Sippel, et al. · Frontiers in Medicine · 25

PDF

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning

2021 · Carolin E. M. Jakob, Ujjwal Mukund Mahajan, et al. · Infection · 21

PDF

Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study

2023 · Lisa Pilgram, Katharina S. Appel, et al. · Infection · 13

PDF

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

2021 · Maximilian J. Schons, Amke Caliebe, et al. · Infection · 13

PDF

Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities

2021 · Marina Rieder, Nadine Gauchel, et al. · Clinical Research in Cardiology · 12

PDF

Knockdown of ICB-1 gene enhanced estrogen responsiveness of ovarian and breast cancer cells

2009 · Anna Konwisorz, Anette Springwald, et al. · Endocrine Related Cancer · 11

PDF

Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease

2021 · Sebastian Cremer, Lisa Pilgram, et al. · PLoS ONE · 10

PDF

Development and validation of a simplified risk score for the prediction of critical COVID‐19 illness in newly diagnosed patients

2021 · Stanislas Werfel, Carolin E. M. Jakob, et al. · Journal of Medical Virology · 7

PDF

The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population—A comparison of two German registries

2024 · Rebecca Hasseli, Frank Hanses, et al. · Frontiers in Medicine · 6

PDF

Disease severity in hospitalized COVID-19 patients: comparing routine surveillance with cohort data from the LEOSS study in 2020 in Germany

2023 · Uwe Koppe, Julia Schilling, et al. · BMC Infectious Diseases · 3

PDF

COVID-19 in patients with cirrhosis: insights from the multinational LEOSS registry

2022 · Jonathan Frederik Brozat, Frank Hanses, et al. · Journal of Hepatology

PDF

Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

2021 · Maximilian J. Schons, Amke Caliebe, et al. · Infection

PDF

Works count: 16

Citation count: 153

H-index: 8

I10-index: 8